Allogene Therapeutics
ALLO
ALLO
170 hedge funds and large institutions have $201M invested in Allogene Therapeutics in 2025 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 61 increasing their positions, 37 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3% less capital invested
Capital invested by funds: $208M → $201M (-$6.87M)
10.89% less ownership
Funds ownership: 83.95% → 73.06% (-11%)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
170
Holding in Top 10
4
Calls
$120K
Puts
$48K
Top Buyers
| 1 | +$4.43M | |
| 2 | +$2.25M | |
| 3 | +$2.11M | |
| 4 |
Two Sigma Investments
New York
|
+$2.11M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.83M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$12.5M | |
| 3 | -$12.4M | |
| 4 |
Goldman Sachs
New York
|
-$5.13M |
| 5 |
FCMV
Foresite Capital Management VI
Larkspur,
California
|
-$3.25M |